QHM-2025-8437 A86013 Denton Park Medical Group Enhanced Services Contract

The procurement process for the "QHM-2025-8437 A86013 Denton Park Medical Group Enhanced Services Contract" is conducted by NHS North East and North Cumbria Integrated Care Board. This process, classified under the health services category, involves awarding a contract to provide enhanced health services such as androgen deprivation injections, PSA monitoring, SMI health checks, and more. Located in the region identified as UKC, the contract began on the 1st of April 2025 and is scheduled to end on the 31st of March 2026.

The procurement was managed through a limited method, specifically a direct award process, in line with the Health Care Services (Provider Selection Regime) regulations 2023. Notably, this award falls outside the provisions of the Procurement Act 2023 and Procurement Regulations 2024. This tender presents opportunities for businesses specialising in healthcare, particularly those equipped to deliver specialised medical services as listed in the contract description.

The procurement's limited method signifies that the award process directly selected Denton Park Medical Group due to lack of realistic alternatives, indicating a potential growth area for firms aiming to establish or further entrench their presence in the UK's healthcare services sector through future tenders. Enterprises that are capable of providing robust health services solutions, especially those aligning with the healthcare needs in the North East and North Cumbria regions, could find similar contracts advantageous for strategic growth.